Application Due Date: January 24, 2022
This Notice of Special Interest (NOSI) is being issued to encourage investigators with expertise and insights germane to post-acute sequelae of SARS-CoV-2 infection (PASC) pathobiology to apply for supplemental funding that would enable them to leverage current awards to rapidly advance understanding of the pathobiological underpinnings of PASC, including the pathogenic mechanisms responsible for persistent symptoms after acute infection and/or pathology in multiple organ/systems that has, or will, lead to clinically significant health problems.
Topics: Biospecimen Science, Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, Asthma, Cancer, Cardiovascular Disease, Cirrhosis, COPD, COVID-19, Diabetes, Gastroesophageal Reflux Disease (GERD), Hidradentis Supporativa, Immune Disorders, HIV, Immunosuppression, Inflammation, Rheumatoid Disorders, Neurological Disorders, Substance Abuse, Community Engagement, Computational Analysis, Computational or Data Science Methods Development, Diagnostics, Antibody Detection, Diagnostics Development, Diagnostic Efficacy, Diagnostic Reliability, Diagnostic Scalability, Viral Detection, Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Organ, Brain, Endocrine, Eye, GI, Heart, Cardiovascular, Kidney, Liver, Lung, Oral Cavity, Skin, Prevention, Prognostics, Research Methods, Organoid Models, Research Tool Development, Social Determinants of Health, Target Population, Children, Elderly, Military Personnel, Pregnant Women, Teens, Treatments, Antibody-based Treatment, Convalescent Serum, Drug Repurposing, Drug Targets, Anti-viral Targets, Immunological Response Targets, Drugs, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors